Harmony Biosciences Management, Inc.
15
5
6
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
53%
8 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Role: collaborator
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Role: lead
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Role: lead
A Study of Pitolisant in Participants With Prader-Willi Syndrome
Role: lead
Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
Role: lead
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Role: lead
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
Role: lead
A Study of HBS-201 (Pitolisant Delayed-release)
Role: lead
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
Role: lead
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Role: collaborator
WAKIX® (Pitolisant) Pregnancy Registry
Role: lead
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
Role: lead
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Role: lead
Pitolisant in Refractory Restless Legs Syndrome
Role: collaborator
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
Role: lead
All 15 trials loaded